IL5RA and asthma: KCNH2 is the target of amiodarone hydrochloride, dofetilide, and sotalolol, IL5RA is the target of Benralizumab, a drug used in severe asthma patients.[74] From these findings, it is clear that EWAS plays an important role in the identification of novel drug targets.